BerandaBNTC • NASDAQ
add
Benitec Biopharma Inc
$13,49
Setelah Jam Perdagangan Normal:(0,00%)0,00
$13,49
Tutup: 7 Jul, 16.01.45 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$13,17
Rentang hari
$12,88 - $13,65
Rentang tahun
$7,05 - $17,15
Kapitalisasi pasar
354,12 jt USD
Volume Rata-Rata
166,62 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 10,19 jt | 145,85% |
Laba bersih | -9,35 jt | -118,60% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | -10,18 jt | -147,21% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 103,58 jt | 632,40% |
Total aset | 105,21 jt | 601,44% |
Total liabilitas | 7,64 jt | 118,32% |
Total ekuitas | 97,57 jt | — |
Saham yang beredar | 25,60 jt | — |
Harga terhadap nilai buku | 3,45 | — |
Tingkat pengembalian aset | -27,64% | — |
Tingkat pengembalian modal | -29,17% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -9,35 jt | -118,60% |
Kas dari operasi | -3,09 jt | 49,97% |
Kas dari investasi | -6,00 rb | 96,65% |
Kas dari pembiayaan | 28,41 jt | — |
Perubahan kas bersih | 25,30 jt | 505,99% |
Arus kas bebas | 60,50 rb | 101,31% |
Tentang
Benitec Biopharma Limited is an Australian biotechnology company founded in 1997. It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference technology.
The CSIRO has researched RNAi extensively, developing the small hairpin RNA concept employed in ddRNAi. Benitec Biopharma has an exclusive license to this ddRNAi technology in human therapeutic uses and research. Wikipedia
Didirikan
1997
Situs
Karyawan
16
